BPC-157 + GHK-Cu + TB-500
Three repair mechanisms — cytoprotection, copper-peptide remodelling and actin-driven migration — in one vial.
Four-peptide repair and anti-inflammatory co-formulation.
| SKU | Per vial | Pack | |
|---|---|---|---|
| KLOW80 | 80 mg (50 + 10 + 10 + 10) | 10 vials / box |
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
An 80 mg vial co-formulating 50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157 and 10 mg KPV. To the triple repair blend it adds KPV, the anti-inflammatory C-terminal tripeptide of α-MSH shown to reduce intestinal inflammation via PepT1 uptake 4. The remaining components are described under BPC-157 1, GHK-Cu 2 and TB-500 3.
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Three repair mechanisms — cytoprotection, copper-peptide remodelling and actin-driven migration — in one vial.
Copper tripeptide with the anti-inflammatory α-MSH tripeptide.